Switch View
© ACCESSWIRE
23.09.2025
ISIN: US47010C4096
Jaguar Health, Inc.
JAGX
LISTED
NASDAQ
Jaguar Health Presenting September 25 at Emerging Growth Conference and September 30 at Lytham Partners Fall 2025 Conference to Provide Updates on Near-Term Catalysts
News Preview
SAN FRANCISCO, CA / ACCESS Newswire / September 23, 2025 / Jaguar Health, Inc. (NASDAQ:JAGX) today announced that Lisa Conte, the company's founder, president and CEO, will present virtually on Thursday, September 25, 2025 at the Emerging Growth Conference and virtually on Tuesday, September 30, 2025 at the Lytham Partners Fall 2025 Conference.Part...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
23.09.2025
ISIN: US03815U4094
Applied DNA Sciences, Inc.
APDN
LISTED
NASDAQ
Applied DNA Abstracts Selected for Poster Presentations Showcasing LineaDNA and LineaIVT Platforms at Upcoming mRNA and CAR T Industry Conferences
News Preview
STONY BROOK, NY / ACCESS Newswire / September 23, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a biotechnology company focused on providing nucleic acid production solutions for the biopharmaceutical and diagnostics industries, announced that members of its business development and technical...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
23.09.2025
ISIN: US5845073056
Medical Care Technologies Inc.
MDCE
LISTED
OTC
Medical Care Technologies Inc. Introduces AI Facial Health Risk Estimator for Cardiovascular Disease Detection
News Preview
MESA, ARIZONA / ACCESS Newswire / September 23, 2025 / Medical Care Technologies Inc. (OTC PINK:MDCE) today announced the launch of its AI Facial Health Risk Estimator, a groundbreaking technology that leverages advanced facial imaging to provide early risk detection for cardiovascular disease, one of the leading causes of death worldwide.The syste...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Leerverkaufsstatistiken, Hedge-Fund Aktivitäten und viele weitere nutzerwertige Informationen benutzerfreundlich aufbereitet
© ACCESSWIRE
23.09.2025
ISIN: US60770K1079
Moderna, Inc
MRNA
LISTED
NASDAQ
Moderna Announces mNEXSPIKE Generates Strong Immune Response Against LP.8.1 Variant in Humans
News Preview
Preliminary analysis showed the 2025-2026 formula of mNEXSPIKE generated greater than a 16-fold increase in LP.8.1-neutralizing antibodies across age groupsBoth of Moderna's COVID-19 vaccines for the 2025-2026 season have demonstrated strong immune responses against today's top circulating COVID-19 strains CAMBRIDGE, MA / ACCESS Newswire / Septembe...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© ACCESSWIRE
23.09.2025
ISIN: US12482V1035
CBD Life Sciences Inc.
CBDL
LISTED
OTC
CBD Life Sciences Inc. (CBDL) Announces LOI With New Jersey Dispensary, Unlocking New Revenue Channels & Strategic Growth Opportunities
News Preview
Strategic collaboration expands CBDL's footprint in the booming East Coast cannabis market projected to surpass $33 billion by 2030, while strengthening retail distribution and cross-brand synergies SCOTTSDALE, AZ / ACCESS Newswire / September 23, 2025 / CBD Life Sciences Inc. (OTC:CBDL), through its wholly owned subsidiary, CBD Vault, is proud to...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
23.09.2025
ISIN: CA98980M1095
Zomedica Corporation
ZOM
LISTED
XASE
Zomedica Expands TRUFORMA(R) Diagnostic Platform with Addition of Feline Use to Cobalamin & Folate Assay
News Preview
First and only in-clinic multiplexed Cobalamin & Folate assay now validated for feline patients ANN ARBOR, MI / ACCESS Newswire / September 23, 2025 / Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica" or the "Company"), a veterinary health company offering innovative point-of-care diagnostic and therapeutic device products for equine...
Themefolio
Profiler
Peergroup
© Globe Newswire
23.09.2025
ISIN: CH0027148649
Santhera Pharmaceuticals Holding AG
SANN
LISTED
SIX
Santhera Announces Half Year 2025 Financial Results and Provides Corporate Update
News Preview
Ad hoc announcement pursuant to Art. 53 LR...
Themefolio
Profiler
Peergroup
© PR Newswire
23.09.2025
ISIN: KYG970081173
WuXi Biologics (Cayman) Inc
2269
LISTED
HKSE
WuXi Biologics Selected as Constituent of FTSE4Good Index Series for Fifth Consecutive Year
News Preview
SHANGHAI, Sept. 23, 2025 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced it has been selected as a constituent company of the FTSE4Good Index Series, marking the fifth consecutive year the company has been recognized by FTSE Russell for outstanding...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
23.09.2025
ISIN: DE000A3MQR65
Viromed Medical AG
Q11
LISTED
XETRA
Viromed Medical AG initiates approval process for PulmoPlas(R) with the Federal Institute for Drugs and Medical Devices (BfArM)
News Preview
RELLINGEN, DE / ACCESS Newswire / September 23, 2025 / Viromed Medical AG ("Viromed"; ISIN: DE000A3MQR65), a medical technology company and pioneer of cold plasma technology, has initiated the official approval process for its new product PulmoPlas® with the Federal Institute for Drugs and Medical Devices („Bundesinstitut für Ar...
Themefolio
Profiler
Peergroup
© Globe Newswire
23.09.2025
ISIN: CH0027148649
Santhera Pharmaceuticals Holding AG
SANN
LISTED
SIX
Santhera Announces Half Year 2025 Financial Results and Provides Corporate Update
News Preview
Ad hoc announcement pursuant to Art. 53 LR...
Themefolio
Profiler
Peergroup
© Globe Newswire
23.09.2025
ISIN: CH0027148649
Santhera Pharmaceuticals Holding AG
SANN
LISTED
SIX
Santhera Secures CHF 20 Million Growth Funding to Accelerate Global AGAMREE® Rollout
News Preview
Ad hoc announcement pursuant to Art. 53 LR...
Themefolio
Profiler
Peergroup
© Globe Newswire
23.09.2025
ISIN: FR0000120578
Sanofi SA
SAN
LISTED
EURONEXT
Press Release: Sanofi’s SAR446268 earns US fast track designation for the treatment of non-congenital myotonic dystrophy type 1
News Preview
Sanofi’s SAR446268 earns US fast track designation for the treatment of non-congenital myotonic dystrophy type 1...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© Globe Newswire
23.09.2025
ISIN: CH0029850754
Addex Therapeutics Ltd
ADXN
LISTED
SIX
Addex Appoints Bank of New York Mellon as Depositary Bank
News Preview
Ad Hoc Announcement Pursuant to Art. 53 LR...
Themefolio
Profiler
Peergroup
© PR Newswire
23.09.2025
ISIN: KYG0146B1032
Akeso, Inc.
9926
LISTED
HKSE
Ivonescimab HARMONi-6 Results Selected for ESMO 2025 LBA; Final Phase III Results of Cadonilimab as First-Line Therapy for Advanced Gastric Cancer to Be Published as an Oral Presentation
News Preview
HONG KONG, Sept. 22, 2025 /PRNewswire/ -- Akeso Inc. (9926.HK) is excited to announce that the Late-Breaking Abstract (LBA) from the registrational Phase III clinical study (AK112-306/HARMONi-6 study) of ivonescimab, a globally first-in-class bispecific antibody targeting PD-1 and VEGF, will be presented at the 2025 European Society for Medical O...
Themefolio
Profiler
Peergroup
© Globe Newswire
23.09.2025
ISIN: KYG211081248
China Medical System Holdings Ltd
867
LISTED
HKSE
China Medical System (867.HK; 8A8.SG) Signed Collaboration Agreements for Two Innovative Biologics Used for Passive Immunization Against Tetanus and Rabies
News Preview
SHENZHEN, CHINA, Sept. 23, 2025 (GLOBE NEWSWIRE) -- China Medical System Holdings Limited (“CMS” or the “Group”) is pleased to announce that on 22 September 2025, the Group through its subsidiaries entered into two separate exclusive Collaboration Agreements (the “Agreements”) with Chongqing Genrix Biopharmaceutical Co., Ltd. (“Genrix Bio”) for t...
Themefolio
Profiler
Peergroup
© PR Newswire
23.09.2025
ISIN: KR7006280002
Green Cross Corporation
006280
LISTED
KOE
GC Biopharma Submits IND Application for Phase 1 Clinical Trial of COVID-19 mRNA Vaccine in Korea
News Preview
YONGIN, South Korea, Sept. 22, 2025 /PRNewswire/ -- GC Biopharma (006280.KS), a leading South Korean pharmaceutical company, announced today that it has submitted an Investigational New Drug (IND) application to the Ministry of Food and Drug Safety (MFDS) in South Korea for a Phase 1 clinical trial of "GC4006A," its mRNA (messenger RNA) vaccine c...
Themefolio
Profiler
Peergroup
© PR Newswire
23.09.2025
ISIN: US02155H1014
Altimmune, Inc.
ALT
LISTED
NASDAQ
ALT Investors Have Opportunity to Lead Altimmune, Inc. Securities Fraud Lawsuit
News Preview
NEW YORK, Sept. 22, 2025 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Altimmune, Inc. (NASDAQ: ALT) between August 10, 2023 and June 25, 2025, both dates inclusive (the "Class Period"), of the important October 6, 2025 lead plaintiff deadline....
Themefolio
Profiler
Peergroup
© Globe Newswire
23.09.2025
ISIN: CA29842P1053
Eupraxia Pharmaceuticals Inc.
EPRX
LISTED
TSX
Eupraxia Pharmaceuticals Announces Pricing of US$70 Million Public Offering of Common Shares
News Preview
VICTORIA, British Columbia, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Eupraxia Pharmaceuticals Inc. (“Eupraxia” or the “Company”) (NASDAQ:EPRX) (TSX:EPRX), a clinical-stage biotechnology company leveraging its proprietary Diffusphere™ technology designed to optimize local, controlled drug delivery for applications with significant unmet need, today anno...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
23.09.2025
ISIN: GB00BYX3WZ24
Hemogenyx Pharmaceuticals plc
HEMO
LISTED
LSE
Hemogenyx Pharmaceuticals PLC Signs Letter of Intent
News Preview
Hemogenyx Pharmaceuticals Signs Letter of Intent with Cellin Technologies to Advance Commercialization of HG-CT-1 CAR-T Therapy in EstoniaFirst Potential Near-Term Revenue Opportunity LONDON / ACCESS Newswire / September 23, 2025 / Hemogenyx Pharmaceuticals plc (LSE:HEMO) is pleased to announce that it has signed a Letter of Intent ("LOI"...
Themefolio
Profiler
Peergroup
© BusinessWire
23.09.2025
ISIN: US23282W6057
Cytokinetics Inc
CYTK
LISTED
NASDAQ
CYTOKINETICS SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, Llc Reminds Investors With Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Cytokinetics, Incorporated - CYTK
News Preview
Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until November 17, 2025 to file lead plaintiff applications in a securities class action lawsuit against Cytokinetics, Incorporated (NasdaqGS: CYTK), if they purchased or otherwise acquired the Company’s s...
Themefolio
Profiler
Peergroup
© PR Newswire
23.09.2025
ISIN: AU000000TLX2
Telix Pharmaceuticals Ltd
TLX
LISTED
ASX
Rosen Law Firm Encourages Telix Pharmaceuticals Ltd. Investors to Inquire About Securities Class Action Investigation - TLX
News Preview
NEW YORK, Sept. 22, 2025 /PRNewswire/ --
Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Telix Pharmaceuticals Ltd. (NASDAQ: TLX) resulting f...
Themefolio
Profiler
Peergroup
© BusinessWire
22.09.2025
ISIN: US4718712023
Jasper Therapeutics, Inc.
JSPR
LISTED
NASDAQ
Jasper Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – JSPR
News Preview
The DJS Law Group reminds investors of a class action lawsuit against Jasper Therapeutics, Inc. (“Jasper” or “the Company”) (NASDAQ: JSPR) violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Shareholders who purchased shares of JSPR during th...
Themefolio
Profiler
Peergroup
© Newsfile
22.09.2025
ISIN: CA87243W1032
THC Biomed Intl Ltd.
THC
LISTED
CSE
CSE Bulletin: Delist - THC Biomed Intl Ltd. (THC)
News Preview
Toronto, Ontario--(Newsfile Corp. - Le 22 septembre/September 2025) - The common shares of THC Biomed Intl Ltd. will be delisted from the CSE at market close today, September 22, 2025. THC Biomed Intl Ltd. is currently suspended. See Bulletin 2024-0202. _________________________________ Les actions ordinaire...
Themefolio
Profiler
Peergroup
© PR Newswire
22.09.2025
ISIN: US4718711033
Jasper Therapeutics, Inc.
JSPR
LISTED
NASDAQ
JSPR Investors Have Opportunity to Lead Jasper Therapeutics, Inc. Securities Fraud Lawsuit
News Preview
NEW YORK, Sept. 22, 2025 /PRNewswire/ --
Why: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Jasper Therapeutics, Inc. (NASDAQ: JSPR) betwe...
Themefolio
Profiler
Peergroup
© BusinessWire
22.09.2025
ISIN: US4718712023
Jasper Therapeutics, Inc.
JSPR
LISTED
NASDAQ
Securities Fraud Investigation Into Jasper Therapeutics, Inc. (JSPR) Announced – Investors Who Lost Money Urged to Contact the Law Offices of Frank R. Cruz
News Preview
The Law Offices of Frank R. Cruz announces an investigation of Jasper Therapeutics, Inc. (“Jasper” or the “Company”) (NASDAQ: JSPR) on behalf of investors concerning the Company’s possible violations of federal securities laws.
IF YOU ARE AN INVESTOR WHO LOST MONEY ON JASPER THERAPEUTICS, INC. (JSPR), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURS...
Themefolio
Profiler
Peergroup
© BusinessWire
22.09.2025
ISIN: US00653Q1022
Adapthealth Corp
AHCO
LISTED
NASDAQ
AdaptHealth Corp. to Participate in Upcoming Investor Conference
News Preview
AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today that they will participate in the Jefferies Healthcare Services Conference, being held in Nashville, on Monday, Se...
Themefolio
Profiler
Peergroup
© BusinessWire
22.09.2025
ISIN: CA60255C8850
Mind Medicine (MindMed) Inc
MNMD
LISTED
NASDAQ
MindMed Announces New Employee Inducement Grants
News Preview
Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the “Company” or “MindMed”), a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced the issuance of inducement grants to three newly hired non-executive employees consisting of options to purchase an aggregate of 182,800 commo...
Themefolio
Profiler
Peergroup
© BusinessWire
22.09.2025
ISIN: US24661P8077
Delcath Systems, Inc.
DCTH
LISTED
NASDAQ
Delcath Systems Announces Investigator-Initiated CHOPIN Phase 2 Trial Presentation at ESMO 2025 Congress
News Preview
Delcath Systems, Inc. (NASDAQ: DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, today announced the acceptance of an oral presentation on results from the investigator-initiated CHOPIN randomized Phase 2 trial at the 2025 European Society for Medical Oncology (ESMO) Annual Congress. Princi...
Themefolio
Profiler
Peergroup
© BusinessWire
22.09.2025
ISIN: US4718712023
Jasper Therapeutics, Inc.
JSPR
LISTED
NASDAQ
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Jasper
News Preview
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Jasper Therapeutics, Inc. (“Jasper” or the “Company”) (NASDAQ: JSPR) and reminds investors of the November 18, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
F...
Themefolio
Profiler
Peergroup
© PR Newswire
22.09.2025
ISIN: US9224751084
Veeva Systems Inc
VEEV
LISTED
NYSE
Bristol Myers Squibb entscheidet sich für Veeva Vault CRM
News Preview
Für CRM der nächsten Generation mit tiefgreifenden, branchenspezifischen KI-Agenten
PLEASANTON, Kalifornien, 22. September 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) gab heute bekannt, dass Bristol Myers Squibb (BMS) sich verpflichtet hat, Veeva Vault CRM.
„Technologie verändert grundlegend die Art und Weise, wie wir mit unseren Kunden und...
Themefolio
Profiler
Peergroup
© Globe Newswire
22.09.2025
ISIN: US0017441017
AMN Healthcare Services Inc
AMN
LISTED
NYSE
AMN Healthcare Announces Pricing of Senior Notes Offering
News Preview
DALLAS, Sept. 22, 2025 (GLOBE NEWSWIRE) -- AMN Healthcare Services, Inc. (NYSE: AMN), announced today that its wholly owned subsidiary, AMN Healthcare, Inc., priced its previously announced private offering of $400.0 million aggregate principal amount of senior unsecured notes due 2031. The 2031 Notes will bear an interest rate of 6.500% per annu...
Themefolio
Profiler
Peergroup
© BusinessWire
22.09.2025
ISIN: US67079U3068
Nutex Health Inc
NUTX
LISTED
NASDAQ
Kirby McInerney LLP Reminds Nutex Health Inc. Investors of Class Action Filing and Encourages Investors to Contact the Firm
News Preview
Kirby McInerney LLP reminds investors who purchased Nutex Health Inc. (“Nutex” or the “Company”) (NASDAQ:NUTX) securities to contact Thomas W. Elrod of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below, to discuss your rights or interests in the securities fraud class action lawsuit at no cost.
If you s...
Themefolio
Profiler
Peergroup
© Globe Newswire
22.09.2025
ISIN: US57777K1060
MaxCyte Inc
MXCT
LISTED
NASDAQ
MaxCyte Announces Operational Restructuring to Reduce Costs and Accelerate Path to Profitability
News Preview
ROCKVILLE, Md., Sept. 22, 2025 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (Nasdaq: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics, today announced a restructuring of its operations to better align resources with it...
Themefolio
Profiler
Peergroup
© Globe Newswire
22.09.2025
ISIN: US34965KAA51
Fortrea Holdings, Inc.
FTRE
LISTED
NASDAQ
Fortrea Appoints William Sharbaugh to Board of Directors
News Preview
DURHAM, N.C., Sept. 22, 2025 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), today announced the appointment of William Sharbaugh to the Company’s Board of Directors. Mr. Sharbaugh brings extensive healthcare experience in finance, operations, manufacturing, and quality to the pos...
Themefolio
Profiler
Peergroup
© BusinessWire
22.09.2025
ISIN: US2183521028
Corcept Therapeutics Inc
CORT
LISTED
NASDAQ
Corcept to Present New Late-Breaking Data From Pivotal ROSELLA Trial of Relacorilant in Platinum-Resistant Ovarian Cancer at ESMO 2025
News Preview
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, will present new data from its pivotal Phase 3 ROSELLA trial of relacorilant plus nab-p...
Themefolio
Profiler
Peergroup
© BusinessWire
22.09.2025
ISIN: US76029N1063
Replimune Group Inc
REPL
LISTED
NASDAQ
FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Replimune
News Preview
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Replimune Group, Inc. (“Replimune” or the “Company”) (NASDAQ: REPL) and reminds investors of the September 22, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
F...
Themefolio
Profiler
Peergroup
© BusinessWire
22.09.2025
ISIN: US78349D1072
Rxsight Inc
RXST
LISTED
NASDAQ
FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of RxSight
News Preview
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against RxSight, Inc. (“RxSight” or the “Company”) (NASDAQ: RXST) and reminds investors of the September 22, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
Faruqi &...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
22.09.2025
ISIN: CA00143Y1034
AI-ML Innovations Inc.
AIML
LISTED
CSE
AIML Announces Closing of Oversubscribed Private Placement
News Preview
VANCOUVER, BC / ACCESS Newswire / September 22, 2025 / AI/ML Innovations Inc. ("AIML" or the "Company") (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB) is pleased to announce that Company completed its previously announced non-brokered private placement offering on September 4, 2025 on an oversubscribed basis.On September 4, 2025, the Company...
Themefolio
Profiler
Peergroup
© Globe Newswire
22.09.2025
ISIN: US55287L1017
MBX Biosciences, Inc.
MBX
LISTED
NASDAQ
MBX Biosciences Announces Proposed Public Offering
News Preview
CARMEL, Ind., Sept. 22, 2025 (GLOBE NEWSWIRE) -- MBX Biosciences, Inc. (Nasdaq: MBX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic disorders, today announced that it has filed a registration statement on Form S-1 with the U.S....
Themefolio
Profiler
Peergroup
© Globe Newswire
22.09.2025
ISIN: FR0004163111
Genfit SA
GNFT
LISTED
EURONEXT
GENFIT Reports First-Half 2025 Financial Results and Provides Corporate Update
News Preview
Lille (France), Cambridge (Massachusetts, United States), (Zurich, Switzerland); September 22, 2025 – GENFIT (Nasdaq and Euronext: GNFT), a late-stage biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, today announced its first half 2025 financial results and provided a corporate up...
Themefolio
Profiler
Peergroup
© Globe Newswire
22.09.2025
ISIN: US04272N1028
Arrivent Biopharma Inc
AVBP
LISTED
NASDAQ
ArriVent Appoints Brent S. Rice as Chief Commercial Officer
News Preview
NEWTOWN SQUARE, Pa., Sept. 22, 2025 (GLOBE NEWSWIRE) -- ArriVent BioPharma, Inc. (Company or ArriVent) (Nasdaq: AVBP), a clinical-stage company dedicated to accelerating the global development of innovative biopharmaceutical therapeutics, today announced the appointment of Brent S. Rice as Chief Commercial Officer (CCO). Mr. Rice joins ArriVent w...
Themefolio
Profiler
Peergroup
© Globe Newswire
22.09.2025
ISIN: US08205P1003
Benitec Biopharma, Inc.
BNTC
LISTED
NASDAQ
Benitec Biopharma Releases Full Year 2025 Financial Results and Provides Operational Update
News Preview
Interim Clinical Study Results for Cohort 1 of the BB-301 Phase 1b/2a Treatment Study Anticipated in Q4 2025...
Themefolio
Profiler
Peergroup
© Globe Newswire
22.09.2025
ISIN: CA29842P1053
Eupraxia Pharmaceuticals Inc.
EPRX
LISTED
TSX
Eupraxia Pharmaceuticals Announces Proposed Public Offering of Common Shares
News Preview
VICTORIA, British Columbia, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Eupraxia Pharmaceuticals Inc. (“Eupraxia” or the “Company”) (NASDAQ:EPRX) (TSX:EPRX), a clinical-stage biotechnology company leveraging its proprietary Diffusphere™ technology designed to optimize local, controlled drug delivery for applications with significant unmet need, is pleased...
Themefolio
Profiler
Peergroup
© Globe Newswire
22.09.2025
ISIN: US5288723027
Lexicon Pharmaceuticals Inc
LXRX
LISTED
NASDAQ
Lexicon Pharmaceuticals Announces Update on Submission of Additional Data to U.S. FDA Supporting the Benefit-Risk Profile of Zynquista® in Type 1 Diabetes
News Preview
Data obtained from ongoing third-party funded, investigator-sponsored trials have been submitted in effort to address the December 2024 complete response letter...
Themefolio
Profiler
Peergroup
© PR Newswire
22.09.2025
ISIN: US81684M1045
Semler Scientific Inc
SMLR
LISTED
NASDAQ
Shareholder Alert: The Ademi Firm investigates whether Semler Scientific Inc. is obtaining a Fair Price for its Public Shareholders
News Preview
MILWAUKEE, Sept. 22, 2025 /PRNewswire/ -- The Ademi Firm is investigating Semler Scientific (Nasdaq: SMLR) for possible breaches of fiduciary duty and other violations of law in its transaction with Strive.
Click here to learn how...
Themefolio
Profiler
Peergroup
© PR Newswire
22.09.2025
ISIN: US5165441032
Lantheus Holdings Inc
LNTH
LISTED
NASDAQ
Lantheus Holdings, Inc. (LNTH) Investors: November 10, 2025 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLP
News Preview
RADNOR, Pa., Sept. 22, 2025 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Lantheus Holdings, Inc. ("Lantheus") (NASDAQ: LNTH) on behalf of those who purchased or otherwise acquired Lantheus securities between February 26, 2025,...
Themefolio
Profiler
Peergroup
© PR Newswire
22.09.2025
ISIN: US1266501006
CVS Health Corp
CVS
LISTED
NYSE
Omnicare Initiates Voluntary Chapter 11 Process
News Preview
Company Intends to Use Process to Implement a Standalone Restructuring or Sale Strategy
Remains Focused on Delivering Safe and Reliable Pharmacy Services to All Customers
WOONSOCKET, R.I., Sept. 22, 2025 /PRNewswire/ -- Omnicare, LLC, a subsidiary of CVS Health (NYSE: CVS), today announced it has initiated a voluntary court-supervised Chapter 11...
Themefolio
Profiler
Peergroup
© BusinessWire
22.09.2025
ISIN: US23282W6057
Cytokinetics Inc
CYTK
LISTED
NASDAQ
Law Offices of Frank R. Cruz Encourages Cytokinetics, Incorporated (CYTK) Investors To Inquire About Securities Fraud Class Action
News Preview
The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of investors who purchased Cytokinetics, Incorporated (“Cytokinetics” or the “Company”) (NASDAQ: CYTK) common stock between December 27, 2023 and May 6, 2025, inclusive (the “Class Period”). Cytokinetics investors have until November 17, 2025 to file a...
Themefolio
Profiler
Peergroup
© PR Newswire
22.09.2025
ISIN: US23282W6057
Cytokinetics Inc
CYTK
LISTED
NASDAQ
CYTK INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Cytokinetics, Incorporated Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
News Preview
NEW YORK, Sept. 22, 2025 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Cytokinetics, Incorporated ("Cytokinetics" or "the Company") (NASDAQ: CYTK) and certain of its officers....
Themefolio
Profiler
Peergroup
© PR Newswire
22.09.2025
ISIN: US59267L1070
Metsera, Inc.
MTSR
LISTED
NASDAQ
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ODP and MTSR on Behalf of Shareholders
News Preview
NEW YORK, Sept. 22, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:...
Themefolio
Profiler
Peergroup
© PR Newswire
22.09.2025
ISIN: US76029N1063
Replimune Group Inc
REPL
LISTED
NASDAQ
REPL Deadline: REPL Investors with Losses in Excess of $100K Have Opportunity to Lead Replimune Group, Inc. Securities Lawsuit Filed by The Rosen Law Firm
News Preview
NEW YORK, Sept. 22, 2025 /PRNewswire/ --
Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Replimune Group, Inc. (NASDAQ: REPL) between November 22, 2024 and July 21, 2025, both dates inclu...
Themefolio
Profiler
Peergroup
© PR Newswire
22.09.2025
ISIN: US5165441032
Lantheus Holdings Inc
LNTH
LISTED
NASDAQ
LNTH INVESTOR DEADLINE: Lantheus Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
News Preview
SAN DIEGO, Sept. 22, 2025 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Lantheus Holdings, Inc. (NASDAQ: LNTH) securities between February 26, 2025 and August 5, 2025, all dates inclusive (the "Class Period"), have until November 10, 2025 to seek appointment as lead plaintiff of the Lantheus class...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
22.09.2025
ISIN: US63633D1046
National Health Investors Inc
NHI
LISTED
NYSE
NHI Prices Offering of Senior Notes
News Preview
MURFREESBORO, TN / ACCESS Newswire / September 22, 2025 / National Health Investors, Inc. (NYSE:NHI) announced today that it priced an offering of $350 million aggregate principal amount of 5.350% Senior Notes due 2033 (the "Notes"). The Notes will be issued at 98.903% of par value with a coupon of 5.350%. Interest on the Notes is payable...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
22.09.2025
ISIN: CA68237C1059
Onco-Innovations Limited
ONCO
LISTED
CSE
Onco-Innovations Appoints Dr. Michael Lock to Scientific & Clinical Advisory Board
News Preview
VANCOUVER, BC / ACCESS Newswire / September 22, 2025 / Onco-Innovations Limited (CBOE CA:ONCO)(Frankfurt:W1H, WKN: A3EKSZ)(OTCQB:ONNVF) ("Onco" or the "Company") is pleased to announce the appointment of Dr. Michael Lock, Professor in the Department of Oncology and the Department of Medical Biophysics at the University of Wester...
Themefolio
Profiler
Peergroup
© Globe Newswire
22.09.2025
ISIN: US17166A1016
Cibus Inc
CBUS
LISTED
NASDAQ
Cibus CEO to Highlight Gene Editing’s Role in Building Resilient Agriculture at UN Climate Week 2025
News Preview
SAN DIEGO, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS), a leading agricultural technology company specializing in the development and licensing of gene-edited plant traits, today announced that Peter Beetham, Co-Founder, President, and Interim Chief Executive Officer, will participate in a featured panel during UN Climate Week 2...
Themefolio
Profiler
Peergroup
© PR Newswire
22.09.2025
ISIN: US9224751084
Veeva Systems Inc
VEEV
LISTED
NYSE
Bristol Myers Squibb Commits to Veeva Vault CRM
News Preview
For next-generation CRM with deep, industry-specific AI agents
PLEASANTON, Calif., Sept. 22, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that Bristol Myers Squibb (BMS) has committed to Veeva Vault CRM.
"Technology is fundamentally reshaping the way we engage with our customers and the patients they serve," said Greg Meyers,...
Themefolio
Profiler
Peergroup
© PR Newswire
22.09.2025
ISIN: US9224751084
Veeva Systems Inc
VEEV
LISTED
NYSE
Bristol Myers Squibb Commits to Veeva Vault CRM
News Preview
For next-generation CRM with deep, industry-specific AI agents
PLEASANTON, Calif., Sept. 22, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that Bristol Myers Squibb (BMS) has committed to Veeva Vault CRM.
"Technol...
Themefolio
Profiler
Peergroup
© PR Newswire
22.09.2025
ISIN: US74051N1028
Premier Inc
PINC
LISTED
NASDAQ
Shareholder Alert: The Ademi Firm investigates whether Premier Inc. is obtaining a Fair Price for its Public Shareholders
News Preview
MILWAUKEE, Sept. 22, 2025 /PRNewswire/ -- The Ademi Firm is investigating Premier (Nasdaq: PINC) for possible breaches of fiduciary duty and other violations of law in its transaction with Patient Square Capital.
Click here to lear...
Themefolio
Profiler
Peergroup
© PR Newswire
22.09.2025
ISIN: US59267L1070
Metsera, Inc.
MTSR
LISTED
NASDAQ
Shareholder Alert: The Ademi Firm investigates whether Metsera Inc. is obtaining a Fair Price for its Public Shareholders
News Preview
MILWAUKEE, Sept. 22, 2025 /PRNewswire/ -- The Ademi Firm is investigating Metsera (Nasdaq: MTSR) for possible breaches of fiduciary duty and other violations of law in its transaction with Pfizer.
Click here to learn how to join ou...
Themefolio
Profiler
Peergroup
© Globe Newswire
22.09.2025
ISIN: BE0003766806
Ion Beam Applications SA
IBAB
LISTED
EURONEXT
IBA – Transparency Notification
News Preview
...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
